🔎 Trials Near Me

Utama › Aterosklerosis › Nebraska

Kajian klinikal Aterosklerosis di Nebraska

7 kajian untuk Aterosklerosis sedang mencari peserta di lokasi di Nebraska.

Bandar di Nebraska

Teks kajian rasmi (Bahasa Inggeris)

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

  • Bryan Heart, Lincoln
  • University of Nebraska Medical Center, Omaha
  • Primary Clinical Research, Papillion
Mengambil pesertaFasa 3
Umur 45 hingga 99 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07037433

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

  • GSR Enterprises, Inc., Lincoln
  • Great Plains Health - Nephrology, North Platte
Mengambil pesertaFasa 2/3
Umur 18 ke atas · Semua jantina · Dikemas kini 21 Sep 2026 · NCT05485961

Detecting Peripheral Artery Disease With the Pulse

  • University of Nebraska at Omaha Health Science Collaborative, Omaha
Mengambil pesertaSukarelawan sihat dialu-alukan
Umur 19 ke atas · Semua jantina · Dikemas kini 17 Sep 2026 · NCT07226193

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

  • Research Site, Elkhorn
  • Research Site, Fremont
  • Research Site, Omaha
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 24 Ogo 2026 · NCT07000357

Oxygen-guided Supervised Exercise Therapy

  • Omaha VA Nebraska-Western Iowa Health Care System, Omaha, NE, Omaha
Mengambil peserta
Semua umur · Semua jantina · Dikemas kini 13 Jan 2026 · NCT06003855

Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes

  • Omaha VA Nebraska-Western Iowa Health Care System, Omaha, NE, Omaha
Mengambil pesertaFasa 4
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Dis 2025 · NCT02915198

Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.